title: The life history of a botulinum toxin molecule.
abstract: There is an emerging literature describing the absorption, distribution, metabolism and elimination of botulinum toxin. This work reveals that the toxin can be absorbed by both the oral and inhalation routes. The primary mechanism for absorption is binding and transport across epithelial cells. Toxin that enters the body undergoes a distribution phase, which is quite short, and an elimination phase, which is comparatively long. During the distribution phase, botulinum toxin migrates to the peri-neuronal microcompartment in the vicinity of vulnerable cells, such as cholinergic nerve endings. Only these cells have the ability to selectively accumulate the molecule. When the toxin moves from the cell membrane to the cell interior, it undergoes programmed death. This is coincident with release of the catalytically active light chain that paralyzes transmission. Intraneuronal metabolism of light chain is via the ubiquitination-proteasome pathway. Systemic metabolism and elimination is assumed to be via the liver. The analysis of absorption, distribution, metabolism and elimination of the toxin helps to create a life history of the molecule in the body. This has many benefits, including: a) clarifying the mechanisms that underlie the disease botulism, b) providing insights for development of medical countermeasures against the toxin, and c) helping to explain the meaning of a lethal dose of toxin. It is likely that work intended to enhance understanding of the fate of botulinum toxin in the body will intensify. These efforts will include new and powerful analytic tools, such as single molecule-single cell analyses in vitro and real time, 3-dimensional pharmacokinetic studies in vivo.
authors.affiliation: Inventox, Inc., Room R-127, LIMR Building, 100 East Lancaster Avenue, Wynnewood, PA 19096, USA. llsone@comcast.net
authors.forename: Lance
authors.initials: L
authors.lastname: Simpson
mesh_terms: D000042:Absorption; D000280:Administration, Inhalation; D000818:Animals; D000907:Antibodies, Bacterial / Q000276:immunology / Q000494:pharmacology; D001428:Bacterial Vaccines / Q000276:immunology; D001904:Botulinum Antitoxin / Q000276:immunology / Q000494:pharmacology; D001905:Botulinum Toxins / Q000737:chemistry* / Q000493:pharmacokinetics*; D001906:Botulism / Q000188:drug therapy / Q000382:microbiology; D004847:Epithelial Cells / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007928:Lethal Dose 50; D008099:Liver / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D009498:Neurotoxins / Q000737:chemistry / Q000493:pharmacokinetics; D013329:Structure-Activity Relationship
chemical_list: D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines; D001904:Botulinum Antitoxin; D009498:Neurotoxins; D001905:Botulinum Toxins